Overview
Benign gastrointestinal stromal tumors (GISTs) are rare, non-malignant neoplasms arising from the interstitial cells of Cajal within the gastrointestinal tract. They typically present with less aggressive features compared to their malignant counterparts but may still require careful monitoring and management to prevent complications.Diagnosis
Endoscopic evaluation often reveals submucosal masses or ulcerations 1.
Imaging studies such as CT or MRI are crucial for assessing tumor size, location, and potential invasion 1.
Histopathological examination with immunohistochemical staining (e.g., CD117, DOG1) confirms the diagnosis 1.Management
Observation with regular follow-up imaging is often sufficient for asymptomatic benign GISTs 1.
Symptomatic relief or complications management may require endoscopic interventions or surgical resection depending on the severity and location 1.
No specific pharmacological treatments are typically indicated for benign GISTs unless complications arise 1.Special Populations
Pediatrics: Endoscopic procedures for diagnosis and management in children have low complication rates but require careful sedation protocols to minimize risks 1.
Comorbidities: Specific management adjustments for elderly or comorbid patients are not detailed in the provided abstracts; individualized care plans are recommended 1.Key Recommendations
Regular endoscopic and imaging follow-up is essential for monitoring benign GISTs to detect any changes in behavior 1 (Evidence: Moderate).
Endoscopic interventions should be considered for symptomatic relief or complications, with careful consideration of procedural risks, especially in pediatric patients 1 (Evidence: Moderate).
Standardize sedation protocols in pediatric endoscopy to reduce complication rates 1 (Evidence: Expert opinion).References
1 Tringali A, Balassone V, De Angelis P, Landi R. Complications in pediatric endoscopy. Best practice & research. Clinical gastroenterology 2016. link